US Stock MarketDetailed Quotes

NUTX Nutex Health

Watchlist
  • 25.1900
  • +2.5700+11.36%
Close Sep 13 16:00 ET
  • 25.1900
  • 0.00000.00%
Post 20:02 ET
127.61MMarket Cap-2905P/E (TTM)

Nutex Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
107,538.69%13.26M
190.00%3.05M
-97.52%1.26M
-139.42%-1.78M
126.96%1.97M
-99.93%12.32K
-97.06%1.05M
-70.82%50.61M
-90.29%4.51M
-130.11%-7.3M
Net income from continuing operations
170.56%3.01M
92.16%-542.49K
89.97%-43.42M
-159.99%-27.71M
98.93%-4.52M
82.22%-4.27M
-127.88%-6.92M
-356.78%-432.74M
-179.10%-10.66M
-667.71%-422.91M
Operating gains losses
---2.61M
---2.6M
----
----
----
----
----
110.13%561.65K
----
----
Depreciation and amortization
8.72%4.53M
4.82%4.19M
33.97%17.59M
43.12%4.68M
9.60%4.75M
33.09%4.17M
66.62%3.99M
71.37%13.13M
82.89%3.27M
131.34%4.33M
Deferred tax
-176.09%-2.25M
89.52%-95.41K
-214.23%-5.71M
-324.46%-3.64M
96.01%-344.42K
-106.77%-813.45K
---910.66K
--5M
--1.62M
---8.64M
Other non cash items
-88.82%108.2K
148.82%262.5K
-30.60%1.4M
-99.87%358
-15.64%326.23K
-25.15%967.69K
79.24%105.49K
5,158.42%2.02M
-94.75%278.63K
164.16%386.72K
Change In working capital
1,408.95%3.85M
-37.91%1.79M
-102.58%-1.66M
-163.64%-5.97M
-91.95%1.72M
-101.17%-294.28K
-65.89%2.89M
2,236.23%64.32M
-70.13%9.38M
141.38%21.31M
-Change in receivables
180.06%397.09K
-144.87%-2.97M
-107.89%-4.58M
-344.14%-8.08M
-107.64%-2.63M
-103.17%-495.97K
40.36%6.62M
976.96%58.08M
-88.58%3.31M
165.02%34.42M
-Change in inventory
-79.12%216.04K
767.68%415.1K
119.84%142.7K
-121.27%-707.87K
24.25%-231.94K
1,219.46%1.03M
8,376.82%47.84K
33.94%-719.11K
70.48%-319.91K
-12,835.95%-306.19K
-Change in prepaid assets
39.14%-2.49M
-23.52%795.92K
42.41%-817.3K
-30.31%2.95M
80.23%-722.95K
-91.70%-4.09M
694.15%1.04M
-508.77%-1.42M
2,230.88%4.24M
-702.30%-3.66M
-Change in payables and accrued expense
75.87%5.73M
173.63%3.55M
-57.06%3.6M
-106.31%-135.65K
157.94%5.3M
-72.31%3.26M
-233.52%-4.82M
-21.69%8.38M
-34.54%2.15M
-1,206.12%-9.15M
Cash from discontinued investing activities
Operating cash flow
107,538.69%13.26M
190.00%3.05M
-97.52%1.26M
-139.42%-1.78M
126.96%1.97M
-99.93%12.32K
-97.06%1.05M
-70.82%50.61M
-90.29%4.51M
-130.11%-7.3M
Investing cash flow
Cash flow from continuing investing activities
58.65%-1.27M
86.46%-733.32K
-159.14%-11.24M
-89.02%865.6K
38.56%-3.62M
-235.53%-3.07M
36.96%-5.42M
88.27%-4.34M
166.95%7.88M
-68.72%-5.89M
Net PPE purchase and sale
81.82%-558.17K
83.25%-733.32K
35.10%-9.5M
-89.52%825.66K
51.18%-2.88M
61.77%-3.07M
49.06%-4.38M
60.37%-14.63M
167.23%7.88M
-68.72%-5.89M
Net business purchase and sale
---711.31K
--0
-116.93%-1.74M
--39.94K
---743.84K
--0
---1.04M
21,173.46%10.3M
--0
--0
Cash from discontinued investing activities
Investing cash flow
58.65%-1.27M
86.46%-733.32K
-159.14%-11.24M
-89.02%865.6K
38.56%-3.62M
-235.53%-3.07M
36.96%-5.42M
88.27%-4.34M
166.95%7.88M
-68.72%-5.89M
Financing cash flow
Cash flow from continuing financing activities
-139.96%-1.19M
93.07%5.69M
95.28%-2.27M
73.47%-3.91M
-293.26%-4.28M
137.74%2.98M
110.63%2.95M
61.75%-48.13M
54.99%-14.75M
109.01%2.21M
Net issuance payments of debt
-103.13%-109.56K
-168.12%-3.03M
147.34%2.65M
78.69%-2.68M
-161.68%-2.63M
143.07%3.5M
242.19%4.45M
-73.58%-5.59M
-1,911.29%-12.59M
251.74%4.26M
Net common stock issuance
--0
--9.2M
----
----
----
--0
--0
----
----
----
Cash dividends paid
-20.11%-1.38M
68.69%-481.29K
89.82%-5.21M
30.14%-879.05K
22.98%-1.65M
92.33%-1.15M
95.32%-1.54M
64.51%-51.23M
97.05%-1.26M
90.79%-2.14M
Proceeds from stock option exercised by employees
----
----
--0
--0
----
----
----
--4.18M
---588.04K
--0
Net other financing activities
----
----
-93.40%298.03K
-12.84%-351.52K
--0
-30.11%621.55K
-99.27%28K
-79.20%4.51M
-103.39%-311.51K
-93.67%94.26K
Cash from discontinued financing activities
Financing cash flow
-139.96%-1.19M
93.07%5.69M
95.28%-2.27M
73.47%-3.91M
-293.26%-4.28M
137.74%2.98M
110.63%2.95M
61.75%-48.13M
54.99%-14.75M
109.01%2.21M
Net cash flow
Beginning cash position
-8.62%30.01M
-35.77%22M
-5.16%34.26M
-26.74%26.83M
-31.19%32.75M
-7.65%32.84M
-5.16%34.26M
41.56%36.12M
6.96%36.62M
25.16%47.6M
Current changes in cash
13,239.78%10.8M
664.19%8M
-557.71%-12.25M
-103.96%-4.82M
46.01%-5.93M
-100.68%-82.21K
-153.44%-1.42M
-117.57%-1.86M
-225.83%-2.37M
-189.44%-10.98M
End cash Position
24.59%40.81M
-8.62%30.01M
-35.77%22M
-35.77%22M
-26.74%26.83M
-31.19%32.75M
-7.65%32.84M
-5.16%34.26M
-5.16%34.26M
6.96%36.62M
Free cash flow
515.42%12.7M
169.70%2.32M
-122.91%-8.24M
-107.67%-950.56K
93.12%-907.25K
-131.75%-3.06M
-112.25%-3.32M
-73.65%35.97M
-64.31%12.39M
-163.54%-13.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 107,538.69%13.26M190.00%3.05M-97.52%1.26M-139.42%-1.78M126.96%1.97M-99.93%12.32K-97.06%1.05M-70.82%50.61M-90.29%4.51M-130.11%-7.3M
Net income from continuing operations 170.56%3.01M92.16%-542.49K89.97%-43.42M-159.99%-27.71M98.93%-4.52M82.22%-4.27M-127.88%-6.92M-356.78%-432.74M-179.10%-10.66M-667.71%-422.91M
Operating gains losses ---2.61M---2.6M--------------------110.13%561.65K--------
Depreciation and amortization 8.72%4.53M4.82%4.19M33.97%17.59M43.12%4.68M9.60%4.75M33.09%4.17M66.62%3.99M71.37%13.13M82.89%3.27M131.34%4.33M
Deferred tax -176.09%-2.25M89.52%-95.41K-214.23%-5.71M-324.46%-3.64M96.01%-344.42K-106.77%-813.45K---910.66K--5M--1.62M---8.64M
Other non cash items -88.82%108.2K148.82%262.5K-30.60%1.4M-99.87%358-15.64%326.23K-25.15%967.69K79.24%105.49K5,158.42%2.02M-94.75%278.63K164.16%386.72K
Change In working capital 1,408.95%3.85M-37.91%1.79M-102.58%-1.66M-163.64%-5.97M-91.95%1.72M-101.17%-294.28K-65.89%2.89M2,236.23%64.32M-70.13%9.38M141.38%21.31M
-Change in receivables 180.06%397.09K-144.87%-2.97M-107.89%-4.58M-344.14%-8.08M-107.64%-2.63M-103.17%-495.97K40.36%6.62M976.96%58.08M-88.58%3.31M165.02%34.42M
-Change in inventory -79.12%216.04K767.68%415.1K119.84%142.7K-121.27%-707.87K24.25%-231.94K1,219.46%1.03M8,376.82%47.84K33.94%-719.11K70.48%-319.91K-12,835.95%-306.19K
-Change in prepaid assets 39.14%-2.49M-23.52%795.92K42.41%-817.3K-30.31%2.95M80.23%-722.95K-91.70%-4.09M694.15%1.04M-508.77%-1.42M2,230.88%4.24M-702.30%-3.66M
-Change in payables and accrued expense 75.87%5.73M173.63%3.55M-57.06%3.6M-106.31%-135.65K157.94%5.3M-72.31%3.26M-233.52%-4.82M-21.69%8.38M-34.54%2.15M-1,206.12%-9.15M
Cash from discontinued investing activities
Operating cash flow 107,538.69%13.26M190.00%3.05M-97.52%1.26M-139.42%-1.78M126.96%1.97M-99.93%12.32K-97.06%1.05M-70.82%50.61M-90.29%4.51M-130.11%-7.3M
Investing cash flow
Cash flow from continuing investing activities 58.65%-1.27M86.46%-733.32K-159.14%-11.24M-89.02%865.6K38.56%-3.62M-235.53%-3.07M36.96%-5.42M88.27%-4.34M166.95%7.88M-68.72%-5.89M
Net PPE purchase and sale 81.82%-558.17K83.25%-733.32K35.10%-9.5M-89.52%825.66K51.18%-2.88M61.77%-3.07M49.06%-4.38M60.37%-14.63M167.23%7.88M-68.72%-5.89M
Net business purchase and sale ---711.31K--0-116.93%-1.74M--39.94K---743.84K--0---1.04M21,173.46%10.3M--0--0
Cash from discontinued investing activities
Investing cash flow 58.65%-1.27M86.46%-733.32K-159.14%-11.24M-89.02%865.6K38.56%-3.62M-235.53%-3.07M36.96%-5.42M88.27%-4.34M166.95%7.88M-68.72%-5.89M
Financing cash flow
Cash flow from continuing financing activities -139.96%-1.19M93.07%5.69M95.28%-2.27M73.47%-3.91M-293.26%-4.28M137.74%2.98M110.63%2.95M61.75%-48.13M54.99%-14.75M109.01%2.21M
Net issuance payments of debt -103.13%-109.56K-168.12%-3.03M147.34%2.65M78.69%-2.68M-161.68%-2.63M143.07%3.5M242.19%4.45M-73.58%-5.59M-1,911.29%-12.59M251.74%4.26M
Net common stock issuance --0--9.2M--------------0--0------------
Cash dividends paid -20.11%-1.38M68.69%-481.29K89.82%-5.21M30.14%-879.05K22.98%-1.65M92.33%-1.15M95.32%-1.54M64.51%-51.23M97.05%-1.26M90.79%-2.14M
Proceeds from stock option exercised by employees ----------0--0--------------4.18M---588.04K--0
Net other financing activities ---------93.40%298.03K-12.84%-351.52K--0-30.11%621.55K-99.27%28K-79.20%4.51M-103.39%-311.51K-93.67%94.26K
Cash from discontinued financing activities
Financing cash flow -139.96%-1.19M93.07%5.69M95.28%-2.27M73.47%-3.91M-293.26%-4.28M137.74%2.98M110.63%2.95M61.75%-48.13M54.99%-14.75M109.01%2.21M
Net cash flow
Beginning cash position -8.62%30.01M-35.77%22M-5.16%34.26M-26.74%26.83M-31.19%32.75M-7.65%32.84M-5.16%34.26M41.56%36.12M6.96%36.62M25.16%47.6M
Current changes in cash 13,239.78%10.8M664.19%8M-557.71%-12.25M-103.96%-4.82M46.01%-5.93M-100.68%-82.21K-153.44%-1.42M-117.57%-1.86M-225.83%-2.37M-189.44%-10.98M
End cash Position 24.59%40.81M-8.62%30.01M-35.77%22M-35.77%22M-26.74%26.83M-31.19%32.75M-7.65%32.84M-5.16%34.26M-5.16%34.26M6.96%36.62M
Free cash flow 515.42%12.7M169.70%2.32M-122.91%-8.24M-107.67%-950.56K93.12%-907.25K-131.75%-3.06M-112.25%-3.32M-73.65%35.97M-64.31%12.39M-163.54%-13.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-4.17%